It inhibits bacterial protein synthesis by hindering the bacterial transpeptidation process. It has antibacterial effects on a variety of Gram-positive aerobic bacteria (such as Staphylococcus aureus, Streptococcus pyogenes, etc.), Gram-negative aerobic bacteria (such as Haemophilus influenzae, Moraxella catarrhalis, etc.), anaerobic bacteria (such as Bacteroides fragilis, Propionibacterium acnes, etc.), sexually transmitted disease microorganisms (such as Treponema pallidum, Neisseria gonorrhoeae, etc.) and other microorganisms (such as Mycoplasma pneumoniae, Chlamydia trachomatis, etc.). The mechanism of action is the same as that of erythromycin, mainly binding to the 50S subunit of the bacterial ribosome to inhibit RNA-dependent protein synthesis.

Pharmacological action not specified

Extract from the above information

Extract from the above information

The antipsychotic effect is related to its ability to block dopamine receptors in the brain and promote the conversion of dopamine in the brain. It has a good effect on resisting hallucinations and delusions and excitement and agitation. It has a strong effect on blocking extrapyramidal dopamine and antiemetic effect, but its sedative effect and blocking effects on adrenaline receptors and cholinergic receptors are weak.